Peptide Hydrogel Scaffold for Mesenchymal Precursor Cells Implanted to Injured Adult Rat Spinal Cord
Authors:
- 16 August 2021
- journal article
- research article
- Published by SAGE Publications in Tissue Engineering Part A
- Vol. 27 (15-16) , 993-1007
Abstract
A unique, biomimetic self-assembling peptide (SAP) hydrogel, Fmoc-DIKVAV, has been shown to be a suitable cell and drug delivery system in the injured brain. In this study, we assessed its utility in adult Fischer 344 (F344) rats as a stabilizing scaffold and vehicle for grafted cells after mild thoracic (thoracic level 10 [T10]) contusion spinal cord injury (SCI). Treatments were as follows: Fmoc-DIKVAV alone, Fmoc-DIKVAV containing viable or nonviable rat mesenchymal precursor cells (rMPCs), and rMPCs alone. The majority of post-SCI treatments were administered at 11–15 days (mean 13.5 days) and the results then compared to SCI-only control (no treatment) rats. Postinjury behavior was quantified using open field locomotion (BBB) and LadderWalk analysis. After perfusion at 8 weeks, longitudinal spinal cord sections were immunostained with a panel of antibodies. Qualitatively, in the SAP-only treatment group, implanted gels contained regenerate axons as well as astrocytic, immune cell, and extracellular matrix (ECM) component profiles. Grafts of Fmoc-DIKVAV plus viable or nonviable rMPCs also contained numerous macrophages/microglia and ECM components, but astrocytes were generally confined to implant margins, and axons were rare. Quantitative analysis showed that, while average cyst size was reduced in all experimental groups, the decrease compared to SCI-only controls was only significant in the SAP and rMPC treatment groups. There was gradual improvement in functionality after SCI, but a consistent trend was only seen between the rMPC treatment group and SCI-only controls. In summary, after contusion SCI, implantation of Fmoc-DIKVAV hydrogel provided a favorable microenvironment for cellular infiltration and axonal regrowth, a supportive role that unexpectedly appeared to be compromised by prior inclusion of rMPCs into the gel matrix. Impact statement: The self-assembling peptide hydrogel, Fmoc-DIKVAV, is a biomimetic scaffold that is an effective cell and drug delivery system in the injured brain. We examined whether this hydrogel, alone or combined with mesenchymal precursor cells, was also able to stabilise spinal cord tissue after thoracic contusion injury and improve morphological and behavioral outcomes. While improved functionality was not consistently seen, there was reduced cyst size and increased tissue sparing in some groups. There was regenerative axonal growth into hydrogels, but only in initially cell-free implants. This type of polymer is a suitable candidate for further testing in spinal cord injury models.Keywords
This publication has 61 references indexed in Scilit:
- Alginate Hydrogels as Scaffolds and Delivery Systems to Repair the Damaged Spinal CordBiotechnology Journal, 2019
- Emerging targets for reprograming the immune response to promote repair and recovery of function after spinal cord injuryCurrent Opinion in Neurology, 2018
- Traumatic Spinal Cord Injury—Repair and RegenerationNeurosurgery, 2017
- Injectable Hydrogels for Spinal Cord Repair: A Focus on Swelling and Intraspinal PressureCells Tissues Organs, 2016
- Injectable Extracellular Matrix Hydrogels as Scaffolds for Spinal Cord Injury RepairTissue Engineering Part A, 2016
- Biomimetic Synthetic Self-Assembled Hydrogels for Cell TransplantationCurrent Topics in Medicinal Chemistry, 2015
- Hydrogels and Cell Based Therapies in Spinal Cord Injury RegenerationStem Cells International, 2015
- Scaffolds to promote spinal cord regenerationHandbook of Clinical Neurology, 2012
- A Systematic Review of Cellular Transplantation Therapies for Spinal Cord InjuryJournal of Neurotrauma, 2011
- Spinal Cord Injury: experimental animal models and relation to human therapy2009